Interview with Yuriy Savko, Executive Director, Association of Pharmaceutical…
What was the vision behind the creation of APRaD back in 2007 and what was lacking in the market at that time that called for such an association? APRaD originated…
Address: 2 Avtozavodskaya
Tel: +38 0445862064
Web: http://nobel.com.ua/
The company NOBEL company NOBEL was founded in 1964 as producing, and selling drugs marketiruyuschaya preparty. In 1978 it became part of the holding ULKAR . Today, ULKAR HOLDING , with its highly qualified staff in 2100, is a multinational pharmaceutical company with headquarters in Istanbul, Turkey.
ULKAR HOLDING consists of:
– Research and Development Center ( FARGEM )
– The production capacity in Turkey ( ULKAR KIMIYA and NOBELFARMA ), Kazakhstan ( NOBEL AFF ) and Uzbekistan ( NOBEL PHARMSANOAT )
– Marketing, promotion and sales organization in Turkey ( NOBEL operates in Turkey with a commando of 850 medical representatives), as well as in 14 countries in Eastern Europe, Central Asia and CIS
– The EU regulatory company located in Germany ( GENERINOBEL )
Drugs that are manufactured and marketiruyutsya by companies within the holding company, are presented in the following treatment groups:
– Analgesics – antipyretics
– Anti-inflammatory and antirheumatic
– Antimicrobials
– Allergy
– Preparations for the treatment of cardiovascular disease
– Cough medicines
– Preparations for the treatment of gastrointestinal diseases
– Preparations for the treatment of genitourinary system
– Preparations for the support of cancer
– Psychiatry
– Diseases of the respiratory tract
What was the vision behind the creation of APRaD back in 2007 and what was lacking in the market at that time that called for such an association? APRaD originated…
You recently switched from Novartis to Unipharm. Given the major differences in environment and portfolio, what was it about Unipharm in particular that attracted you and what are you bringing…
Since 2006 Teva has been on a solid phase of growth and consolidation, mainly through the acquisitions of IVAX in 2006, Pliva (Barr) in 2008 and ratiopharm in 2010, which…
Following Takeda’s acquisition of Nycomed earlier this year, how has the transaction affected your operations in Ukraine and what synergies were generated by it? Regarding the integration process, we are…
If you could provide our readers with your philosophy when you founded Sayenko Kharenko in 2004. What were the market needs that were perhaps missing that you identified and wanted…
It has been one year since you were appointed as the head of UCB’s operations in Ukraine. What was the mission of your assignment when you took this position and…
Considering you only took over as CEO from your father in 2009, what was the mandate that was given to you as new CEO of the company – including your…
Orion’s global strategy focuses on the CIS and Eastern European markets that still exhibit large growth potential and are expanding, despite a reverse trend for the rest of the industry.…
What were the factors that led to Sanofi’s decision to establish an LLC in 2009 in Ukraine, and how has it changed your operations? Most of the major foreign companies…
Ipsen has showed some very positive results worldwide in 2010 and so far this year, specifically in non-Western European markets that grew by 12% in 2010. How have the Ukrainian…
Since the establishment of Astellas’ predecessor Brocade in Russia in 1992, what has been Astellas’ evolution in Ukraine? Astellas has been present in Ukraine for 16 years, first as Yamanouchi…
See our Cookie Privacy Policy Here
